In the BioHarmony Drug Report Database

"Preview" Icon

Benzhydrocodone

Apadaz (benzhydrocodone) is a small molecule pharmaceutical. Benzhydrocodone was first approved as Apadaz on 2018-02-23. It is used to treat pain in the USA. Apadaz’s patents are valid until 2031-02-22 (FDA).

 

Trade Name

 

Apadaz
 

Common Name

 

benzhydrocodone
 

ChEMBL ID

 

CHEMBL3137321
 

Indication

 

pain
 

Drug Class

 

Image (chem structure or protein)

Benzhydrocodone structure rendering